Cargando…
Effect of MED-02 Containing Two Probiotic Strains, Limosilactobacillus fermentum MG4231 and MG4244, on Body Fat Reduction in Overweight or Obese Subjects: A Randomized, Multicenter, Double-Blind, Placebo-Controlled Study
MED-02 is a complex supplement containing two probiotic strains, Limosilactobacillus fermentum MG4231 and MG4244, isolated from humans. The anti-obesity effects and safety profile of MED-02 were assessed in overweight and obese subjects. In this randomized, double-blinded, placebo-controlled, multic...
Autores principales: | Cho, Young Gyu, Yang, Yun Jun, Yoon, Yeong Sook, Lee, Eon Sook, Lee, Jun Hyung, Jeong, Yulah, Kang, Chang Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9460810/ https://www.ncbi.nlm.nih.gov/pubmed/36079841 http://dx.doi.org/10.3390/nu14173583 |
Ejemplares similares
-
Limosilactobacillus fermentum MG7011: An Amylase and Phytase Producing Starter for the Preparation of Rice-Based Probiotic Beverages
por: Jo, Yu Mi, et al.
Publicado: (2021) -
Limosilactobacillus fermentum MG4295 Improves Hyperglycemia in High-Fat Diet-Induced Mice
por: Kim, Ji Eun, et al.
Publicado: (2022) -
Limosilactobacillus fermentum MG4294 and Lactiplantibacillus plantarum MG5289 Ameliorates Nonalcoholic Fatty Liver Disease in High-Fat Diet-Induced Mice
por: Lee, Ji Yeon, et al.
Publicado: (2023) -
Characteristics and Whole-Genome Analysis of Limosilactobacillus fermentum Phage LFP02
por: Lv, Ruirui, et al.
Publicado: (2023) -
Probiotic effects of Lacticaseibacillus rhamnosus 1155 and Limosilactobacillus fermentum 2644 on hyperuricemic rats
por: Li, Yanjun, et al.
Publicado: (2022)